The itching, redness and swelling of an allergic reaction are caused by mast cells — the vigilant first responders of the immune system that spring into action with histamine-filled granules in response to a perceived threat.
WashU Nephrology proudly congratulates Benjamin Humphreys, MD, PhD, Chief of the Division of Nephrology, on his appointment as an Associate Editor for the Journal of Clinical Investigation (JCI).
Jeffrey Miner, PhD, FASN, Eduardo and Judith Slatopolsky Professor of Medicine in Nephrology at Washington University, was among the 35 workshop participants of the Alport Syndrome Research & Regulatory Workshop recently held in Cambridge, MA.
Anne Mobley Butler, PhD, MS, Associate Professor of Medicine in the Division of Infectious Diseases at WashU Medicine, was senior author of a study published in JAMA Network Open about the incidence of serious perinatal outcomes when treated for a urinary tract infection (UTI) during pregnancy . Co-authors include Michael Durkin, MD, MPH, Associate Professor of Medicine in […]
Smoother skin, smaller pores, better hydration — these are just a few of the many benefits facials can offer. And who isn’t relaxed after being horizontal for an hour while someone massages your face and tends to your pores?
Researchers at the WashU Medicine Sah Lab in the Center for Cardiovascular Research and their collaborators have published findings that provide a proof of concept for a novel drug class to treat myocardial infarction and stroke. Rajan Sah, MD, PhD, a professor of medicine in the cardiovascular division, worked with multiple teams that collaborated to observe and describe a […]
Physicians who divide their time between patients’ bedsides and the laboratory bench play a pivotal role in developing innovative new approaches to diagnosing and treating diseases. The Dean’s Scholars initiative at Washington University School of Medicine in St. Louis was formed in 2020 to support early-career doctors who also conduct biomedical research by providing them with up […]
Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study, led by researchers at Washington University School of Medicine in St. Louis, takes a deep dive into inherited cancer mutations measured in a healthy blood sample and reports how […]
As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing needles or other injection equipment and can also be passed from a mother to baby during pregnancy or childbirth. It can be […]
William H. McCoy IV, MD, PhD, Assistant Professor in the Division of Dermatology at Washington University School of Medicine in St. Louis, recently published a manuscript in the Journal of Investigative Dermatology (JID).
Michael Lin, MD, SFHM, is an Associate Professor of Medicine and Senior Fellow of Hospital Medicine in the Division of Hospital Medicine. Dr. Lin is an integral part of the division and the hospital, having served on multiple committees for both WashU Medicine and BJC, and as the president-elect of the Barnes-Jewish Hospital Medical Staff […]
Early this year, not long after President Donald Trump took office, his administration started terminating grants awarded by the National Institutes of Health (NIH), disrupting studies and unmooring biomedical and public health research communities.
Researchers at the WashU Medicine Sah Lab in the Center for Cardiovascular Research and their collaborators have published findings that provide a proof of concept for a novel drug class to treat myocardial infarction and stroke. Rajan Sah, MD, PhD, a professor of medicine in the cardiovascular division, worked with multiple teams that collaborated to observe and describe a […]
June is national cancer survivorship awareness month. Siteman Cancer Center operates a survivorship clinic, a much needed community resource. As, thanks to cancer research, there are currently more than 18 million people living with a history of cancer in the US.
Max Petersen, MD, PhD, Assistant Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at WashU Medicine, has been awarded the prestigious 2025 Career Development Award from the American Heart Association (AHA).
The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.
The Spark Change Award honors leaders who catalyze transformation—not only through bold ideas, but also through the daily, persistent work of creating more inclusive, just communities. Julia was nominated by colleagues and selected by the Spark Change Award Selection Committee to be one of two inaugural recipients of this award.
Yili Fang, MD, PhD, a Postdoctoral Research Scholar in the Ying Maggie Chen laboratory, has been awarded a prestigious 2025 American Heart Association (AHA) Postdoctoral Fellowship for his project “Develop a Biotherapeutic Protein to Treat Uromodulin-Associated Chronic Kidney Disease (CKD).”
A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular degeneration, a leading cause of blindness in people over age 50. The WashU Medicine researchers and their international collaborators implicated problems with cholesterol metabolism in this type of vision loss, perhaps […]
The LIGHT Creativity in Public Health Summer Camp at WashU encourages students to tap into their imaginations and lived experiences to create artwork, poetry and stories that communicate the importance of health and science.
Kai Jones, MD, Assistant Professor of Medicine in WashU Medicine’s Division of Endocrinology, Metabolism & Lipid Research, has been additionally appointed Associate Program Director for the Department of Medicine’s Internal Medicine Residency Program, effective May 15, 2025.
Philip Payne, PhD, director of I2DB and inaugural Chief Health AI Officer for WashU Medicine and BJC Health System, has long advocated for an “AI Code of Conduct” that pertains to the responsible, effective, equitable, and human-centered use of AI in medicine.
Implementation of clinical genetic testing into the routine diagnostic workup of patients with kidney disorders can improve care when employed with proper patient selection. Due to advances in technology, testing with curated gene panels associated with kidney diseases are commercially available, are relatively inexpensive, and have quick turnaround time.
The 15th Annual Gateway Hospital Medicine Conference took place from May 1, 2025, to May 3, 2025, at the Eric P. Newman Education Center (EPNEC). The Gateway Conference planning committee, composed of adult and pediatric physicians, nurse practitioners, physician assistants, and pharmacists, put extensive effort into designing, planning, and implementing the agenda for the conference.
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University School of Medicine in St. Louis.
WashU Medicine physicians Jiayi Huang, MD, (left) and Milan Chheda, MD, named associate directors of The Brain Tumor Center. The Brain Tumor Center at Siteman Cancer Center, a multidisciplinary practice of physicians and scientists, has named two board-certified WashU Medicine faculty members as associate directors. They are:
Lynn Cornelius, MD, the Winfred and Emma Showman Professor of Dermatology and chief of the Division of Dermatology at WashU Medicine, has been honored with the 2025 Research Achievement Award in Public Policy and Education from the American Skin Association. The award, given May 9 at the Society of Investigative D
David H. Perlmutter, MD, executive vice chancellor for medical affairs and the George and Carol Bauer Dean of Washington University School of Medicine in St. Louis, will conclude his deanship on June 30, 2026, according to Chancellor Andrew D. Martin.
In March, Janet B. McGill, MD, MA, FACE, FACP; Julie M. Silverstein, MD; and Sina Jasim, MD, MPH, of WashU Medicine’s Division of Endocrinology, Metabolism & Lipid Research, published the fifth edition of The Washington Manual Endocrinology Subspecialty Consult.
‘Don’t Fry Day’ is designated by the National Council on Skin Cancer Prevention (NCSCP) and is held on the Friday before Memorial Day each year. Friday morning, Siteman Cancer Center and American Cancer Society stopped by the Show Me Studios to raise awareness about sun safety and skin cancer prevention. They explain that the goal […]
Mark Thoelke, MD, has had an incredible impact on hospital medicine, both within Barnes-Jewish Hospital and beyond. After completing his internal medicine residency and serving as Chief Resident at Jewish Hospital in St. Louis, Dr. Thoelke became Director of the Gold Service in 1995, one of the earliest hospitalist programs in the nation.
With the U.S. Food and Drug Administration (FDA) approval of transcatheter tricuspid valve replacement (TTVR) and transcatheter edge-to-edge repair (T-TEER) procedures for tricuspid regurgitation treatment, heart specialists at the Washington University and Barnes-Jewish Heart & Vascular Center in St. Louis, Mo., are pioneering advances that enhance the quality of life for patients who have historically suffered debilitating […]
When it comes to questions about fungal infections, Andrej Spec, MD, has become the go-to expert for doctors around the world. Each week, he takes 10 to 15 calls from physicians struggling with complex fungal diagnosis or treatment questions. He has fielded queries from all across the U.S. and as far away as China, Thailand, Japan, […]
When a young patient under the care of WashU Medicine physicians Amit Pawale, MD, and Joel Schilling, MD, PhD, was admitted to the intensive care unit at Barnes-Jewish Hospital with heart failure, time was of the essence.
Justin Vader, MD, a WashU Medicine cardiologist and heart failure specialist at Barnes-Jewish Hospital, often sees patients with heart failure who are so sick by the time they enter care at Barnes-Jewish Hospital, that they require extracorporeal membrane oxygenation (ECMO). Fortunately, the heart failure team is often able to stabilize such patients and transition them to a platform […]
The Big Ideas Program invites innovative proposals that use data, advanced analytics (including artificial intelligence or AI), and workflow re-design to address critical clinical and operational needs that impact the quality, safety, outcomes, and value of healthcare delivery.
On April 24, 2025, the Office of Technology Management hosted the eighth annual Celebration of Inventors, an event to honor and recognize Washington University inventors, researchers and faculty entrepreneurs.
Community engagement is woven into the fabric of WashU Medicine. Guided by a deep commitment to helping others, many faculty have built lasting community partnerships that drive innovative care, education and community-engaged research.
In a clinical trial, researchers find moxidectin, a new medicine for river blindness, also works for lymphatic filariasis
The Briefcase Coach, a boutique executive career PR firm, recently published a list of “50 Women Shaping the Future of St. Louis” through visionary leadership, bold innovation, and deep commitment to service. These women excel across many fields and are driving meaningful change to their communities.
In January, Marina Litvin, MD, an Associate Professor of Medicine at WashU Medicine’s Division of Endocrinology, Metabolism and Lipid Research, published an editorial titled “Metabolic Syndrome in the Post-ETI Era” in the Journal of Cystic Fibrosis.
An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the immunotherapy drug pembrolizumab (brand name Keytruda) to standard-of-care therapy.
Anita Palmer Corbin learned to meet challenges head-on when she was diagnosed with Type 1 diabetes at age 10 in 1964. Her mother first noticed the symptoms, and after blood tests confirmed a problem, she was admitted to Cardinal Glennon Children’s Hospital in St. Louis, located one hour north of her home in Ste. Genevieve, […]
Since 2016, Dr. Linda Peterson has spearheaded Project Heartstrong- a school outreach program to bring heart health education to the Normandy School District in North St. Louis County. Every February since, she and a growing team of division faculty and staff have visited classrooms with kid-approved interactive lessons.
A dedicated group of hospitalists are advancing diagnostic excellence under the leadership of Radha Devi, MD, and Timothy Evans, MD, through our Division’s Center for Diagnostic Excellence (DexEx).
The Clinical Research Training Center (CRTC) TL1 trainees recently attended the Association for Clinical and Translational Science (ACTS) 2025 conference in Washington, DC. Held from April 14 to April 17, this four-day conference offered our trainees the opportunity to represent not only our program, but also the broader mission of WashU Medicine.
Janice Hanson, PhD, EdS, MH, Professor of Medicine & Director of Education Scholarship Development in the Division of General Medicine & Geriatrics, was awarded the COMSEP Achievement Award and honored as the 2025 CGEA Laureate.
On October 4, the American Academy of Sleep Medicine published an article titled “How weight loss medications are changing the sleep field,” featuring an interview with Raymond E. Bourey, MD, FAASM. Dr. Bourey has board certification, 25 years in sleep medicine, and is an Associate Professor of Medicine with WashU Medicine’s Division of Endocrinology, Metabolism and Lipid Research.
Finding expert heart care, personalized treatment, and the unwavering support she needed, Geri Lynn Arrindell recently crossed her biggest finish line yet—completing her 100th half-marathon.
Faculty and other members of the Diwan Lab, including Professor of Medicine and Chief of Cardiology at the St. Louis VA Hospital Abhinav Diwan, MD, have published a new paper titled “Phosphorylation of CRYAB induces a condensatopathy to worsen post–myocardial infarction left ventricular remodeling”. The work was chosen for the cover feature of the latest issue of the Journal […]